INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Public company

MIRMMirum Pharmaceuticals, Inc.

CIK 0001759425

EDGAR filingsOpen in network
Disclosed transactions32
Buys / sells0 / 7
Max Insider Score42
Connections7with evidence

MIRM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
18
PC
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1.80M
20.0K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER · Nov 4, 2026
  • ← Insider ofevidence
    Myers Robert PaulChief Medical Officer · Oct 14, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA RR 2026 third quarter · Health issues · Sep 7, 2026
11
PC
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M
—
20.0K sh
Nov 4, 2026
Nov 4, 2026
traded Nov 4, 2026
+0d
SEC FORM 4

Evidence

6
PC
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$59K
20.0K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

23
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M$310K
16.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
16.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC FORM 4

Evidence

15
MP
Myers Robert PaulChief Medical Officer
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
25.0K sh
Oct 9, 2026Oct 14, 2026
traded Oct 9, 2026
+5dSEC FORM 4

Evidence

15
MP
Myers Robert PaulChief Medical Officer
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
40.0K sh
Oct 9, 2026Oct 14, 2026
traded Oct 9, 2026
+5dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
40.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC FORM 4

Evidence

38
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$4.00M
40.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC FORM 4

Evidence

23
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M$251K
40.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC FORM 4

Evidence

15
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$264K
2,594 sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
9,000 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
11.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
25.1K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
18.1K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
20.0K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
16.3K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
34.5K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
7,680 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
4,970 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC FORM 4

Evidence

13
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

34
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$81K
842 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC FORM 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

21
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
4,167 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

17
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
4,167 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

38
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$170K
1,822 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC FORM 4

Evidence

38
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$222K
2,382 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC FORM 4

Evidence

21
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,542 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

42
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$86K
926 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC FORM 4

Evidence

21
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,542 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

21
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
3,334 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

17
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
3,334 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Quan JoanneCHIEF MEDICAL OFFICER · Jan 23, 2026
  • ← Insider ofevidence
    Howe JolandaSVP, GLOBAL CONTROLLER · Jan 23, 2026
  • ← Insider ofevidence
    Radovich PeterPRESIDENT AND COO · Jan 23, 2026

    • Lobbying

    $0 reported · de-duplicated
    2026 Q3 $0 via firms
    • LMH STRATEGIC SOLUTIONS—2026 Q3 · posted Sep 7, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.

    Data sources
    SEC FORM 47m ago
    HOUSE PTR6m ago
    SEC 13F6m ago
    ROBINHOOD CHAIN6m ago